Award
National Institute of Diabetes and Digestive and Kidney Diseases 5K23DK125839-05
Genetics, glycemic control and the microbiome in cystic fibrosis
Recipient
Massachusetts General Hospital
Award Amount
$199,745.00
Ceiling
$199,745.00
Awarded
July 09, 2024
Identifier
5K23DK125839-05
Award for a clinical trial studying the microbiome in cystic fibrosis patients with CFRD, focusing on glycemic control and genetic factors, using artificial pancreas technology and microbiome analysis.
Description
This project focuses on studying the microbiome in cystic fibrosis patients with CFRD, including the impact of glycemic control and genetic factors. It involves a clinical trial with the use of artificial pancreas technology and microbiome analysis techniques.